Related Experiment Videos
[Effect of naloxone in traumatic shock]
Biulleten' Eksperimental'Noi Biologii I Meditsiny
|December 1, 1983
Summary
Naloxone did not affect vital signs in rabbits experiencing traumatic shock. However, endogenous opioid peptides may offer protection during the shock phase, suggesting a potential therapeutic target.
Area of Science:
- Pharmacology
- Physiology
- Toxicology
Context:
- Traumatic shock is a complex physiological response with high mortality.
- Endogenous opioid peptides are implicated in stress and pain modulation.
- Naloxone is a known opioid antagonist used to reverse opioid effects.
Purpose:
- To investigate the role of endogenous opioid peptides in traumatic shock using naloxone as an antagonist.
- To determine the effect of naloxone on physiological parameters and survival in a rabbit model of traumatic shock.
Summary:
- Intravenous administration of naloxone (0.1-1.0 mg/kg) in rabbits 2-15 minutes post-trauma did not alter arterial pressure or heart rate.
- Animals subjected to traumatic shock exhibited a decreased lifespan compared to control groups.
- The findings suggest a potential protective and adaptive role for endogenous opioid peptides during the torpid phase of traumatic shock.
Impact:
- Highlights the potential involvement of the endogenous opioid system in the pathophysiology of traumatic shock.
- Suggests that endogenous opioid peptides may have a beneficial role in mitigating the effects of traumatic shock.
- Opens avenues for exploring opioid receptor modulation as a therapeutic strategy for traumatic shock.